World Stroke Organization 
;
🎥Recording Available on Optimizing Antiplatelet Therapy in Stroke, chaired by Prof. @Simona_Sacco_ , featuring:
- Prof. Bezerra on Dual Antiplatelet Therapy
- Prof. Newman on Genetic Testing (CYP2C19)
👉https://shorturl.at/lZ41D
#StrokeEducation @WorldStrokeOrg @genedriveplc
▶️Now available: Antithrombotic Therapy for Atherosclerotic Stroke Prevention
𝐖𝐀𝐓𝐂𝐇 𝐈𝐓 𝐇𝐄𝐑𝐄: https://www.youtube.com/watch?v=A0hFgWU2LnI&feature=youtu.be
💎Epidemiology & Pathophysiology
💎Current Evidence & Emerging Treatments
💎Factor XI Future Perspectives
#StrokeEducation @WorldStrokeOrg @Bayer
#MondayTip
Branch Atheromatous Disease
🧠 Pathophysiology → large vessel atherosclerosis
🩺 Clinical picture → small vessel (lacunar) syndromes
🔍 Produces large “lacunar” infarcts in perforator territories
☝️Related to 📈early neurological deterioration
https://doi.org/10.1212/wnl.39.9.1246
Join us Fri 18th, 5-6pm CEST for a webinar on optimizing antiplatelet therapy in stroke care with Prof. Sacco, Prof. Bezerra & Prof. Newman
🧬We’ll cover dual therapy & CYP2C19 genetic testing - supported by @genedriveplc
👉Register: https://us02web.zoom.us/webinar/register/WN_G18OW94-TSOG5vag...
#StrokeEducation
